Commentary|Videos|November 20, 2026

Four Ways to Boost Awareness, Access for COVID-19 PEP

Fact checked by: Ashley Gallagher, MA

Florin Draica, MD, MBA, of Shionogi outlines how clinicians and pharmacies can expand access to ensitrelvir postexposure prophylaxis.

Captions are auto-generated.

Patient and clinician awareness are of the utmost importance when considering postexposure prophylaxis (PEP) like ensitrelvir (Xocova; Shionogi) for COVID-19, especially for patients with underlying chronic conditions.

But awareness is only 1 piece of what Florin Draica, MD, MBA, senior vice president of US medical affairs at Shionogi, described as a “multipronged, multifactorial approach” in an interview with The American Journal of Managed Care® (AJMC®). Knowing who is eligible for the drug is another area clinicians should focus on, he said. When health care providers (HCPs) are familiar with which patients would benefit, it makes it easier for them to identify those patients before an exposure. Additionally, clinicians should be informed on how to manage patients taking ensitrelvir, as it comes with drug interactions and contraindications for them to be aware of, he explained.

“The third tier is when you think about the health care system. So it’s important that institutional health care—so IDNs [integrated delivery networks] and health care facilities—consider developing or updating their COVID-19 protocols,” Draica said.

Last, pharmacies also play a key role, specifically in advising patients on the medication. Pharmacists should be familiar with it, know when and how to recommend it, and have it at the ready or be able to deliver it quickly, he said.

“The time is of the essence with antivirals and the earlier, the better with postexposure prophylaxis,” Draica said.

The role clinicians play in helping patients understand their preventive options is vital as the fall and winter surge approaches. Addressing patients before exposure is key to reaching the most vulnerable populations, specifically older adults and those who have underlying chronic conditions or are immunocompromised.

“They can explain that after a known household exposure, [patients] can call their HCP right away, and different to what patients might think, they shouldn’t think about needing to have a positive test or symptoms,” he said. The purpose of PEP is to intervene before either occurs, Draica explained.


Related to this article